National Scleroderma Foundation
Promotes Compounding Pharmacy Profession
Based in TX
🤖
AI Overview
With $360K in lobbying spend across 36 quarterly filings, National Scleroderma Foundation is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2025.
$360K
Total Spend
8
Years Active
1
Firms Hired
5
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $40K |
| 2019 | $40K |
| 2020 | $50K |
| 2021 | $40K |
| 2022 | $40K |
| 2023 | $60K |
| 2024 | $50K |
| 2025 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues
- •FY17 & FY18 L-HHS Appropriations Bills (Medical Research & Public Health Programs)
- •FY17 & FY18 DoD Appropriations Bills (Research Programs)
- •Scleroderma & Fibrosis Research
- •21st Century Cures Implementation
- •Patients Access to Treatments Act
- •Access to Marketplace Insurance Act
- •Healthcare Reform, Patient Protections
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.